Convatec Group PLC ADR CNVVY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 477.96M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 25.47
- Price/Sales
- 2.65
- Dividend Yield (Trailing)
- 2.25%
- Dividend Yield (Forward)
- 2.25%
- Dividend Payment Schedule
- Jun, Oct
- Total Yield
- 7.41%
Company Profile
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute care hospital and chronic care home settings. Advanced wound care and ostomy supplies are the largest divisions, accounting for 32% and 28% of total revenue, respectively. Continence care has become a slightly smaller business (22% of revenue) following the decision to exit the acute care market, and infusion sets contribute 18% of consolidated revenue.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Core
- Total Number of Employees
- 10,000
- Website
- https://www.convatecgroup.com
Competitors
Valuation
|
Metric
|
CNVVY
|
COLO B
|
BDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.47 | 37.31 | 15.30 |
Price/Book Value | 4.54 | 8.17 | 2.22 |
Price/Sales | 2.65 | 3.84 | 2.81 |
Price/Cash Flow | 14.31 | 13.95 | 15.01 |
Price/Earnings
CNVVY
COLO B
BDX
Financial Strength
|
Metric
|
CNVVY
|
COLO B
|
BDX
|
|---|---|---|---|
Quick Ratio | 1.06 | 0.88 | 0.36 |
Current Ratio | 1.93 | 1.56 | 0.94 |
Interest Coverage | 3.34 | 6.65 | 3.53 |
Quick Ratio
CNVVY
COLO B
BDX
Profitability
|
Metric
|
CNVVY
|
COLO B
|
BDX
|
|---|---|---|---|
Return on Assets (Normalized) | 9.54% | 11.86% | 4.97% |
Return on Equity (Normalized) | 22.72% | 38.99% | 10.63% |
Return on Invested Capital (Normalized) | 13.15% | 15.76% | 7.26% |
Return on Assets
CNVVY
COLO B
BDX
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|%g%>Z?v | LOCK|F%# | $160B | |||
| Becton Dickinson & Co
BDX
| LOCK|w@ | LOCK|tMM#^ | $54B | |||
| ResMed Inc
RMD
| LOCK|VJ?TZPq | LOCK|J&XxJ | $36B | |||
| Alcon Inc
ALC
| LOCK|^bmVn<# | LOCK|>?^?m | $34B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|s!QmXN | LOCK|K<LtJ | $30B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|$%@W@h% | LOCK|@# | $28B | |||
| Solventum Corp
SOLV
| LOCK|^F>&<$> | LOCK|w^ | $15B | |||
| Baxter International Inc
BAX
| LOCK|z# | LOCK|fb?P | $13B | |||
| The Cooper Companies Inc
COO
| LOCK|jf@$B#& | LOCK|Ltl! | $12B | |||
| Repligen Corp
RGEN
| LOCK|Q>?!<x$ | LOCK|F##J& | $11B |
United States